Summary
- Current Price
- As of today, SYRE price is $87.56, up +0.59% in the most recent trading session on
- Current Price All-Time High
- SYRE price is currently -72.53% below its historical high of $318.75 set on
- Market Cap
- SYRE current market cap is $8B, up +656.20% over the past 365 days
- Revenue
- SYRE current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for SYRE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Spyre Therapeutics, Inc. |
| Ticker | NASDAQ: SYRE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | spyre.com |
| Employees | 73 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $87.56 | |
| Price, 1D Change | +0.59% | |
| $8B | ||
| - | ||
| - | ||
| 1.85 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.98 | ||
| EPS, 1Y Change | +37.88% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | AGLE | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.98 | ||
| EPS Estimate | -$2.83 | N/A |
| EPS Est. Change | -43.26% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $87.56 | |
| Price Target | $121.00 | - |
| Price Tgt. Change | +38.19% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.30 | -$3.18 | +25.97% | |
| -$2.12 | -$1.98 | +6.66% | |
| -$2.83 | N/A | -43.26% | |
| -$3.43 | N/A | -73.85% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.09M | $0.00 | -100.00% | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $87.56 | |
| $61.34 | ||
| $98.05 | ||
| $68.19 | ||
| $95.41 | ||
| -$2.48 | ||
| 1.85 | ||
| $5.71 | ||
| 32.27 | ||
| 62.21% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.98 | ||
| $0.00 | ||
| - | ||
| -$219.56M | ||
| - | ||
| -$126.54M | ||
| - | ||
| -$219.56M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 13.25 | ||
| 13.25 | ||
| - | ||
| - | ||
| 72.21 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 8.09 | ||
| -24.23 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $559.42M | ||
| $756.53M | ||
| $777.78M | ||
| $777.78M | ||
| $62.55M | ||
| $58.69M | ||
| $0.00 | ||
| $0.00 | ||
| $8.90M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $126.54M | ||
| $219.56M | ||
| $0.00 | ||
| $47.91M | ||
| $0.00 | ||
| $0.00 | ||
| -$15.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$169.41M | ||
| -$143.48M | ||
| $309.19M | ||
| $0.00 | ||
| -$169.41M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| BTIG | → | |
| Wells Fargo | → | |
| Wedbush | → | |
| Guggenheim | → | |
| Wolfe Research | → | |
| Mizuho | → | |
| Deutsche Bank | → | |
| BTIG | → | |
| Deutsche Bank | → | |
| Stifel | → |
Analyst sentiment
Institutional ownership
No data
Screeners with SYRE
FAQ
- What is the ticker symbol for Spyre Therapeutics, Inc.?
- The ticker symbol for Spyre Therapeutics, Inc. is NASDAQ:SYRE
- Does Spyre Therapeutics, Inc. pay dividends?
- No, Spyre Therapeutics, Inc. does not pay dividends
- What sector is Spyre Therapeutics, Inc. in?
- Spyre Therapeutics, Inc. is in the Healthcare sector
- What industry is Spyre Therapeutics, Inc. in?
- Spyre Therapeutics, Inc. is in the Biotechnology industry
- What country is Spyre Therapeutics, Inc. based in?
- Spyre Therapeutics, Inc. is headquartered in United States
- When did Spyre Therapeutics, Inc. go public?
- Spyre Therapeutics, Inc. initial public offering (IPO) was on April 7, 2016
- Is Spyre Therapeutics, Inc. in the S&P 500?
- No, Spyre Therapeutics, Inc. is not included in the S&P 500 index
- Is Spyre Therapeutics, Inc. in the NASDAQ 100?
- No, Spyre Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Spyre Therapeutics, Inc. in the Dow Jones?
- No, Spyre Therapeutics, Inc. is not included in the Dow Jones index
- When was Spyre Therapeutics, Inc. last earnings report?
- Spyre Therapeutics, Inc.'s most recent earnings report was on August 4, 2026
- When does Spyre Therapeutics, Inc. report earnings?
- The next expected earnings date for Spyre Therapeutics, Inc. is November 3, 2026
Data Sources & References
- SYRE Official Website www.spyre.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1636282/000163628226000020/0001636282-26-000020-index.htm
- SYRE Profile on Yahoo Finance finance.yahoo.com/quote/SYRE
- SYRE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/syre